Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Tenet Huatai Technological Development was a China-based operating subsidiary associated with Shineco's legacy Luobuma business. The company specialized in development and manufacturing of Luobuma-derived products, including functional textiles and nutritional or health-related consumer products rooted in traditional Chinese herbal materials. Public disclosures describe Tenet Huatai as a 90%-owned subsidiary of Beijing Tenet-Jove and part of Shineco's northern China operations centered in Tianjin and Beijing. More recent Shineco filings refer to Tenet Huatai as a former subsidiary, indicating that it is no longer an active core operating entity within the group's current business structure. The business appears to have been commercial-stage rather than a drug-development biotech company, with no disclosed modern therapeutic pipeline or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Tenet Huatai Technological Development.